Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 17 Oct 2025

Senescent immune cells in the tumor microenvironment: emerging insights into cancer immunotherapy resistance

in Cancer Immunity and Immunotherapy

Duolun Gao
Peiyan Kan
Yanjie He
Siyu Sun
Lei Tang
Fan Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1656733

185 views

Editorial

Published on 17 Oct 2025

Editorial: Community series in immune responses against tumors - from the bench to the bedside, volume II

in Cancer Immunity and Immunotherapy

Chun Jing Wang
Shisan Bao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1719075

126 views

Review

Published on 17 Oct 2025

Smart nanocarriers for cancer: harnessing exosomes and lipid systems in photodynamic and immunotherapy

in Cancer Immunity and Immunotherapy

Amrita Swain
Soumya Ranjan Jena
Luna Samanta

Frontiers in Immunology

doi 10.3389/fimmu.2025.1687953

133 views

Correction

Published on 17 Oct 2025

Correction: Editorial: Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance

in Cancer Immunity and Immunotherapy

Sheila Spada
Anirban Ganguly

Frontiers in Immunology

doi 10.3389/fimmu.2025.1720080

Review

Published on 17 Oct 2025

Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives

in Cancer Immunity and Immunotherapy

Yao Lu
Huiping Yuan
Shaojie Liang
Debing Li
Pengfei Jiang
Xian Wang
Ke Zhang
Dechun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1603658

Original Research

Published on 17 Oct 2025

Comprehensive analysis of single-cell and bulk transcriptomes reveals key B-cell genes and immune microenvironment regulation in bladder cancer

in Cancer Immunity and Immunotherapy

Lijun Wang
Juan Yang
Zhangxiao Xu
Bo Tao
Yunpeng He
Yuan Zhao
Jian Wu
Yiran Ma
Zitao Zhong
Lin Ye

Frontiers in Immunology

doi 10.3389/fimmu.2025.1600254

155 views

Mini Review

Published on 17 Oct 2025

TGF-β–driven T-cell exclusion in ovarian cancer: single-cell and spatial transcriptomic views of immune low-response states

in Cancer Immunity and Immunotherapy

Jiang He
Jun Tao
Yu Zhou
Hongjian Li
Wenqi Feng
Yongqiang Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1698088

575 views

Original Research

Published on 17 Oct 2025

Correlation of immune cell subsets in the tumor microenvironment and peripheral blood with immunotherapy response in esophageal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Wei Chen
Lian Gong
Yahu Li
Mengyao Wu
Min Tao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633748

180 views

Review

Published on 17 Oct 2025

Biomarkers and immunotherapy in endometrial cancer: mechanisms and clinical applications

in Cancer Immunity and Immunotherapy

Lianfang Zhao
Xiaohong Li
Yaling Jing
Liping Tang
Fang Lin
Yongqiang Zhang
Yuqin Tang
Chuanliang Chen
Jiayan Yang
Xiaofang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1684549

161 views

Original Research

Published on 17 Oct 2025

Subtype-specific NK cell-TAM interactions drive a novel prognostic signature in HNSCC

in Cancer Immunity and Immunotherapy

Zhenyan Zhao
Xuejiao Han
Yating Hu
Yun Li
Yaodong He
Yan Wang
Yanbing Yao
Huan Li
Jianhua Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1676878

202 views

Perspective

Accepted on 16 Oct 2025

A Novel Multi-layered Immune Structural Model for Peripheral Blood Immune Scoring in Cancer Patients: Perspective and Hypothesis

in Cancer Immunity and Immunotherapy

Hao Jin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1675411

Original Research

Accepted on 16 Oct 2025

A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving durvalumab in combination with tremelimumab

in Cancer Immunity and Immunotherapy

Yang Cheng
Mingji Zhang
Yi Yao
Mingzuo Wang
Zhong Xue
Zhaoshuo Chen
Fan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1657398

Review

Accepted on 16 Oct 2025

Circulating plasma cells: from basic mechanisms to clinical applications

in Cancer Immunity and Immunotherapy

Pingping Wang
Nan Su
Xiaojing Yan
Feng Xu
Yan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1674088

Original Research

Accepted on 16 Oct 2025

Machine learning-based tumor associated macrophages polarity signature predicts prognosis and treatment response in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Fangzhou Wang
Quan Zhang
Yamin Zheng
Shichun Lu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1663519

Case Report

Accepted on 16 Oct 2025

Case Report: a neoantigen-targeting peptide vaccine combined with checkpoint inhibition induces tumor regression and long-term remission in a pediatric patient with metastatic hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Germano Amorelli
Armin Rabsteyn
Claus-Philipp Maier
Finn Trautner
Ursula Holzer
Jürgen Frank Schäfer
Martin Ebinger
Rupert Handgtretinger
Sven Nahnsen
Hans-Georg --- Rammensee

Frontiers in Immunology

doi 10.3389/fimmu.2025.1674663

Original Research

Accepted on 16 Oct 2025

Targeting Pin1 to Overcome Immunosuppressive Tumor Microenvironment in MSS Colorectal Cancer

in Cancer Immunity and Immunotherapy

Jian Wang
Shuxin Tang
Jinhua Fan
Huihui Xiao
Shihua Wang
Jianqin Xiang
Zhili Liu
Hongying Liu
Zhigang Pei
Dequan Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1677029